NCT03977389 (DTDPESERF) is a clinical trial of Total wrist denervation in Wrist Arthritis, sponsored by University Hospital, Brest.

Who is sponsoring NCT03977389?

NCT03977389 is sponsored by University Hospital, Brest.

What drugs are being tested in NCT03977389?

Interventions in NCT03977389: Total wrist denervation.

What condition does NCT03977389 study?

NCT03977389 studies Wrist Arthritis, Survival.

Is NCT03977389 still recruiting?

NCT03977389 is currently completed. Last updated 28 February 2020.

Last reviewed 2020-02-28 · How we verify

NCT03977389: DTDPESERF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Total Wrist Denervation: Survival Study and Functional Outcomes

Completed Last updated 28 February 2020

What this trial tests

trial testing Total wrist denervation in Wrist Arthritis in 63 participants. Completed in 30 March 2018.

Timeline

20 March 2018

Primary endpoint
30 March 2018

30 March 2018

Quick facts

Lead sponsor	University Hospital, Brest
Status	Completed
Study type	OBSERVATIONAL
Enrollment	63
Start date	20 March 2018
Primary completion	30 March 2018
Estimated completion	30 March 2018
Sites	1 location across France

Drugs / interventions tested

Total wrist denervation

Conditions studied

Wrist Arthritis — all drugs for Wrist Arthritis →
Survival — all drugs for Survival →

Sponsor

University Hospital, Brest

Who can join

Eligibility, any sex, with Wrist Arthritis or Survival. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to evaluate the long-term effectiveness of total wrist denervation on pain by assessing the surgery survival. The residual functional wrist's quality and the patients' satisfaction will also be evaluate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wrist Arthritis

Currently open trials in the same condition.

NCT03315377 — Lunatocapitate Fusion Versus Four-corner Fusion for SNAC and SLAC Arthritis. · NA · active not recruiting

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03977389 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 28 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03977389.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing